Skip to content
Clinical Trials – home

Ocular myasthenia Diagnostics

2 / 3 trials open to patients16 countries

In short

Ocular myasthenia gravis is diagnosed through a combination of clinical examination, specialized tests, and blood work to confirm this eye muscle weakness condition. Understanding the diagnostic process can help patients know what to expect when seeking medical evaluation for symptoms like drooping eyelids or double vision.

Key points

  • Ocular myasthenia diagnosis starts with clinical examination, focusing on how your eye muscles behave when fatigued and after rest
  • The ice pack test is a simple, non-invasive way doctors can help confirm the diagnosis right in the office
  • Only about 50 percent of people with ocular myasthenia test positive for the most common antibody, so a negative blood test doesn't rule out the condition
  • Single fiber electromyography (SFEMG) is the most accurate test for myasthenia when performed by experienced practitioners
  • Eye muscles are structurally different from other body muscles, making them especially vulnerable to myasthenia's effects
  • If you have only eye symptoms with no weakness in swallowing, speaking, breathing, arms, or legs, this pattern helps doctors identify ocular rather than generalized myasthenia
  • A chest CT scan is necessary after diagnosis to check for thymus gland abnormalities that could affect treatment
  • Optometrists are often the first to suspect myasthenia and will refer you to a neurologist for specialized testing

Introduction: When to Seek Diagnostic Testing

If you notice your eyelids drooping, see double images instead of one, or have trouble focusing your eyes, especially as the day goes on, it may be time to seek diagnostic testing for ocular myasthenia. These symptoms can significantly affect your daily life, making reading, driving, or even simple tasks challenging. Many people first notice these problems and visit their optician, who may be among the first medical professionals to suspect myasthenia and refer you to a specialist.

About half of all people with myasthenia gravis present initially with only eye-related symptoms. While these symptoms might seem minor at first, getting a proper diagnosis is important. Eye weakness often changes from day to day and throughout the day, typically worsening after prolonged use of your eyes or at the end of the day. If you have ocular myasthenia, you will not have difficulty swallowing, speaking, or breathing, and you will not experience weakness in your arms and legs. These symptoms only affecting the eyes help distinguish ocular myasthenia from the generalized form.

Classic Diagnostic Methods

Diagnosing ocular myasthenia gravis begins with a thorough evaluation by your doctor. The diagnostic process involves several steps and may include multiple types of tests to confirm the condition and rule out other possibilities.

Clinical Examination

Your doctor will start by asking detailed questions about your symptoms and performing a careful physical examination. This is not just a quick look at your eyes. The examination focuses on testing your eyelids and eye movements in specific ways. The doctor will carefully observe what happens to your muscles when they become fatigued and what happens after they have rested. This pattern of fatigue and recovery is a hallmark of myasthenia.

During the examination, your doctor may ask you to look in different directions for extended periods or keep your eyes open for a long time. This helps reveal muscle weakness that might not be obvious at first glance. The goal is to see if your symptoms can be reproduced in the office setting, which helps confirm the diagnosis.

Ice Pack Test

One simple but effective test used to diagnose ocular myasthenia is called the ice pack test, sometimes also called the ice test. In this test, a doctor places an ice pack over your drooping eyelid for a few minutes. If the drooping temporarily improves after cooling, this supports a diagnosis of myasthenia. The test is non-invasive and can provide quick, helpful information.

Blood Tests for Antibodies

A key part of diagnosing ocular myasthenia involves blood tests to look for specific antibodies – special proteins made by your immune system. In myasthenia gravis, these antibodies mistakenly attack the connection between your nerves and muscles. The most common antibody test looks for anti-acetylcholine receptor antibodies, often shortened to AChR antibodies.

However, it's important to understand that these blood tests are not perfect for ocular myasthenia. The anti-acetylcholine receptor antibodies are positive in only about 50 percent of people with ocular myasthenia, meaning that half of people with the condition may have a negative blood test. In comparison, these antibodies are found in nearly 90 percent of people with generalized myasthenia gravis.

Other antibody tests may be performed as well. Doctors may check for antibodies against muscle-specific tyrosine kinase (MuSK) and low-density lipoprotein receptor-related protein 4 (LRP4). These are other proteins involved in nerve-muscle communication. While these tests are helpful, their exact diagnostic value in ocular myasthenia is still being understood.

Electrical Tests of Nerve and Muscle Function

When blood tests are negative or results are unclear, doctors may recommend specialized electrical testing. These tests measure how well your nerves are communicating with your muscles. One type is called a nerve conduction study or electromyogram, often shortened to EMG. During part of this test, a small electrical stimulation is delivered to a nerve, and the responses are measured from a muscle. The test can reveal patterns that suggest myasthenia gravis.

A more specialized version is called single fiber electromyography, or SFEMG. This test uses very small needles that can measure responses from two nearby muscle fibers. The SFEMG is considered the most accurate test for diagnosing myasthenia gravis when performed by experienced practitioners. It is particularly valuable for diagnosing ocular myasthenia when other tests are inconclusive.

For ocular myasthenia specifically, these electrical tests may be performed on the facial muscles rather than muscles elsewhere in the body. This helps focus the testing on the area where symptoms are occurring.

Edrophonium Test

Some doctors may use a medication test called the edrophonium test, also known as the Tensilon test. During this test, a short-acting medication is given through an injection. If the medication temporarily improves your muscle strength or reduces your eye symptoms, this supports a diagnosis of myasthenia gravis. The medication works very quickly but wears off within minutes.

Imaging Studies

If myasthenia gravis is diagnosed, your doctor should order a CT scan of your chest. This imaging test is performed to look for abnormalities in the thymus gland, a small organ in your chest that is part of your immune system. In some people with myasthenia, the thymus is abnormal or contains a benign tumor called a thymoma. Finding these abnormalities is important because they may affect treatment decisions.

Your doctor may also order other imaging tests, such as an MRI, depending on your specific symptoms and situation. These help rule out other conditions that might cause similar symptoms.

Diagnostics for Clinical Trial Qualification

The sources provided do not contain specific information about diagnostic tests or criteria used for enrolling patients in clinical trials for ocular myasthenia gravis. Clinical trials typically use the same diagnostic methods described above to confirm a patient has the condition, but may have additional specific requirements that vary from study to study.

Did you know?

  1. The simple act of placing ice on a drooping eyelid can help diagnose myasthenia – if the eyelid lifts temporarily with cooling, this suggests the diagnosis.
  2. Eye muscles are structurally different from other muscles in your body and have fewer acetylcholine receptors, which may explain why they are so vulnerable to myasthenia gravis.
  3. About 15 percent of people with myasthenia gravis will only ever have eye symptoms, even years after diagnosis, and never develop weakness in other parts of their body.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Ocular myasthenia

Recruiting trials first

See all 3 trials →
Quick filters

3 clinical trials in this condition

Ocular myasthenia

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
See all 3 trials →filters applied: condition = Ocular myasthenia

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).